Literature DB >> 33558811

How Antiepileptics May Change the Serum Level of Vitamin D, Calcium, and Phosphorus in Children with Epilepsy.

Sasan Saket1, Neda Varasteh2, Ali Asghar Halimi Asl3, Hedyeh Saneifard4.   

Abstract

OBJECTIVE: Studies have shown vitamin (Vit) D deficiency and bone disease in long-term use of antiepileptics, especially in young individuals. This study aimed to determine the relationship between antiepileptic drugs and the level of Vit D, calcium (Ca), and phosphorus (P) in children with epilepsy at the Shohada Hospital from 2016 to 2017. MATERIALS &
METHODS: In this case-control study, 60 consecutive children with epilepsy at the Shohada Hospital from 2016 to 2017 under treatment with anticonvulsions for more than six months were enrolled as the case group. The level of Vit D, Ca, and P was determined in the case group and compared with 60 children without seizure as the control group.
RESULTS: The mean Ca and P were alike across the groups (P > 0.05). The mean Vit D3 level was 31.3 and 40 in the case and control groups, respectively, with significant difference (P=0.0001). The mean Ca and P were alike across the types of drug in the case group (P > 0.05); however, the mean Vit D3 level was lower in the case versus control group with significant difference (P=0.040).
CONCLUSION: Totally, according to the obtained results, it may be concluded that treatment with antiepileptic drugs, especially stimulant type, is related to the lower Vit D3 level, but not to the Ca and P levels.

Entities:  

Year:  2021        PMID: 33558811      PMCID: PMC7856441          DOI: 10.22037/ijcn.v15i1.25952

Source DB:  PubMed          Journal:  Iran J Child Neurol        ISSN: 1735-4668


  23 in total

1.  The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.

Authors:  Hepsen Mine Serin; Zehra Pınar Koç; Berfin Temelli; İhsan Esen
Journal:  Epilepsy Behav       Date:  2015-08-24       Impact factor: 2.937

2.  Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs.

Authors:  E Keck; B Gollnick; D Reinhardt; D Karch; H Peerenboom; H L Krüskemper
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

3.  A comparison of single and multi-site BMC measurements for assessment of spine fracture probability.

Authors:  R D Wasnich; P D Ross; J W Davis; J M Vogel
Journal:  J Nucl Med       Date:  1989-07       Impact factor: 10.057

4.  Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.

Authors:  Ola Albaghdadi; Mohammad Salem Alhalabi; Zaynab Alourfi; Lama A Youssef
Journal:  Clin Neurol Neurosurg       Date:  2016-04-26       Impact factor: 1.876

5.  Antiepileptic drugs and bone metabolism in children: data from 128 patients.

Authors:  Peter Borusiak; Thorsten Langer; Marion Heruth; Michael Karenfort; Ulrich Bettendorf; Andreas C W Jenke
Journal:  J Child Neurol       Date:  2012-05-01       Impact factor: 1.987

6.  Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants.

Authors:  L Tjellesen; C Christiansen
Journal:  Acta Neurol Scand       Date:  1982-09       Impact factor: 3.209

7.  Anticonvulsant drugs and bone metabolism.

Authors:  G Bogliun; E Beghi; V Crespi; L Delodovici; P d'Amico
Journal:  Acta Neurol Scand       Date:  1986-10       Impact factor: 3.209

8.  Effect of carbamazepine and valproate on bone mineral density.

Authors:  R D Sheth; C A Wesolowski; J C Jacob; S Penney; G R Hobbs; J E Riggs; J B Bodensteiner
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

9.  Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients.

Authors:  Jaydip Ray Chaudhuri; Kandadai Rukmini Mridula; Chakrala Rathnakishore; Banda Balaraju; Vcs Srinivasarao Bandaru
Journal:  Iran J Child Neurol       Date:  2017

10.  Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up.

Authors:  Seung Ho Lee; Jeesuk Yu
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.